$ATER
Aterian, Inc.

2023 Q1 Form 10-K Financial Statement

#000095017023008509 Filed on March 16, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022 Q3
Revenue $34.88M $54.90M $66.33M
YoY Change -16.3% -13.3% -2.64%
Cost Of Revenue $15.78M $34.53M $36.14M
YoY Change -12.64% 0.27% 6.45%
Gross Profit $19.10M $20.37M $30.19M
YoY Change -19.1% -29.48% -11.66%
Gross Profit Margin 54.75% 37.1% 45.52%
Selling, General & Admin $26.19M $41.27M $44.16M
YoY Change -19.47% -6.1% 2.27%
% of Gross Profit 137.12% 202.6% 146.27%
Research & Development $1.247M $1.430M $1.706M
YoY Change 9.0% -45.36% -38.34%
% of Gross Profit 6.53% 7.02% 5.65%
Depreciation & Amortization $1.762M $1.758M $1.869M
YoY Change -4.55% -31.57% -0.16%
% of Gross Profit 9.23% 8.63% 6.19%
Operating Expenses $44.09M $42.70M $139.1M
YoY Change 42.77% 32.82% 233.63%
Operating Profit -$25.00M -$22.33M -$108.9M
YoY Change 243.48% 583.83% 1347.34%
Interest Expense $596.0K $2.275M $904.0K
YoY Change -25.69% -392.42% -69.03%
% of Operating Profit
Other Income/Expense, Net -$54.00K $83.00K $174.0K
YoY Change -99.07% -4250.0% -3580.0%
Pretax Income -$25.77M -$20.44M -$117.0M
YoY Change -39.75% 232.8% 5.83%
Income Tax $26.00K -$133.0K -$75.00K
% Of Pretax Income
Net Earnings -$25.80M -$20.30M -$116.9M
YoY Change -39.69% 207.22% 5.74%
Net Earnings / Revenue -73.97% -36.98% -176.25%
Basic Earnings Per Share -$0.34 -$1.81
Diluted Earnings Per Share -$0.34 -$0.27 -$1.81
COMMON SHARES
Basic Shares Outstanding 81.00M 80.87M 69.47M
Diluted Shares Outstanding 76.73M 64.65M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.91M $43.57M $26.00M
YoY Change -23.42% 43.73% -30.62%
Cash & Equivalents $33.91M $43.57M $26.00M
Short-Term Investments
Other Short-Term Assets $6.870M $8.261M $10.46M
YoY Change -48.88% -60.73% -18.49%
Inventory $40.38M $43.67M $60.46M
Prepaid Expenses
Receivables $3.486M $4.515M $4.933M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $84.65M $100.0M $101.8M
YoY Change -39.11% -19.91% -22.18%
LONG-TERM ASSETS
Property, Plant & Equipment $830.0K $853.0K $856.0K
YoY Change -27.57% -31.98% -34.1%
Goodwill $0.00 $500.0K $0.00
YoY Change -99.58% -100.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $753.0K $813.0K $2.564M
YoY Change -72.38% -68.07% -27.69%
Total Long-Term Assets $37.98M $56.42M $59.69M
YoY Change -75.97% -70.1% -68.72%
TOTAL ASSETS
Total Short-Term Assets $84.65M $100.0M $101.8M
Total Long-Term Assets $37.98M $56.42M $59.69M
Total Assets $122.6M $156.4M $161.5M
YoY Change -58.72% -50.11% -49.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.955M $16.04M $13.49M
YoY Change -60.88% -26.16% -45.25%
Accrued Expenses $12.62M $14.25M $13.81M
YoY Change -14.22% -16.31% -19.86%
Deferred Revenue
YoY Change
Short-Term Debt $20.41M $22.75M $26.25M
YoY Change -39.17% -43.73% 197.33%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $42.41M $53.04M $60.58M
YoY Change -57.23% -36.67% -8.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $1.447M $1.452M $1.673M
YoY Change 184.28% 303.33% -90.19%
Total Long-Term Liabilities $1.447M $1.452M $1.673M
YoY Change 184.28% 303.33% -96.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $42.41M $53.04M $60.58M
Total Long-Term Liabilities $1.447M $1.452M $1.673M
Total Liabilities $43.85M $54.49M $62.25M
YoY Change -56.0% -39.01% -42.91%
SHAREHOLDERS EQUITY
Retained Earnings -$651.1M -$625.3M -$604.9M
YoY Change 45.76%
Common Stock $730.8M $728.3M $705.8M
YoY Change 11.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $78.77M $102.0M $99.28M
YoY Change
Total Liabilities & Shareholders Equity $122.6M $156.4M $161.5M
YoY Change -58.72% -50.11% -49.79%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$25.80M -$20.30M -$116.9M
YoY Change -39.69% 207.22% 5.74%
Depreciation, Depletion And Amortization $1.762M $1.758M $1.869M
YoY Change -4.55% -31.57% -0.16%
Cash From Operating Activities -$7.417M $2.064M $2.570M
YoY Change -43.68% -235.79% -133.76%
INVESTING ACTIVITIES
Capital Expenditures $125.0K $648.0K -$13.00K
YoY Change -881.25% -3700.0% -121.67%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$158.0K -$648.0K -$13.00K
YoY Change 887.5% 3500.0% -121.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.985M 15.76M -10.24M
YoY Change -113.75% 5208.08% -38.52%
NET CHANGE
Cash From Operating Activities -7.417M 2.064M 2.570M
Cash From Investing Activities -158.0K -648.0K -13.00K
Cash From Financing Activities -2.985M 15.76M -10.24M
Net Change In Cash -10.43M 17.18M -7.681M
YoY Change -224.79% -1484.45% -68.27%
FREE CASH FLOW
Cash From Operating Activities -$7.417M $2.064M $2.570M
Capital Expenditures $125.0K $648.0K -$13.00K
Free Cash Flow -$7.542M $1.416M $2.583M
YoY Change -42.66% -194.27% -133.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001757715
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-1739858
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
37 East 18th Street
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
7th Floor
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.aterian.io/20221231#AccruedExpensesAndOtherLiabilitiesCurrent
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-38937
CY2022 dei Entity Registrant Name
EntityRegistrantName
Aterian, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10003
CY2022 dei City Area Code
CityAreaCode
(347)
CY2022 dei Local Phone Number
LocalPhoneNumber
676-1681
CY2022 dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
CY2022 dei Trading Symbol
TradingSymbol
ATER
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
142100000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81000989
CY2022 dei Auditor Firm
AuditorFirmId
34
CY2022 dei Auditor Location
AuditorLocation
New York, New York
CY2021Q4 us-gaap Cash
Cash
30317000
CY2022Q4 us-gaap Cash
Cash
43574000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10478000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4515000
CY2021Q4 us-gaap Inventory Net
InventoryNet
63045000
CY2022Q4 us-gaap Inventory Net
InventoryNet
43666000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21034000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8261000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
124874000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
100016000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1254000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
853000
CY2021Q4 us-gaap Goodwill
Goodwill
119941000
CY2021Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
64955000
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
54757000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2546000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
813000
CY2021Q4 us-gaap Assets
Assets
313570000
CY2022Q4 us-gaap Assets
Assets
156439000
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
32845000
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
21053000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
21716000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16035000
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
7577000
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1693000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
3983000
CY2021Q4 ater Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
17621000
CY2022Q4 ater Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
14254000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
83742000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
53035000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
360000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1452000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
5240000
CY2021Q4 us-gaap Liabilities
Liabilities
89342000
CY2022Q4 us-gaap Liabilities
Liabilities
54487000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55090237
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80752290
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
5000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
8000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
653650000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
728339000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-428959000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-625251000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-468000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1144000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
224228000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
101952000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
313570000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
156439000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
247767000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
221170000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
125904000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
115652000
CY2021 us-gaap Gross Profit
GrossProfit
121863000
CY2022 us-gaap Gross Profit
GrossProfit
105518000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
127369000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
121139000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9837000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6012000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45099000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38239000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
120409000
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3118000
CY2021 ater Settlement Charge Of Contingent Earnout Liability
SettlementChargeOfContingentEarnoutLiability
4164000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-30529000
CY2022 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-5240000
CY2021 us-gaap Operating Expenses
OperatingExpenses
155940000
CY2022 us-gaap Operating Expenses
OperatingExpenses
283677000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-34077000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-178159000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-12655000
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2603000
CY2022 ater Gain Loss On Extinguishment Of Seller Note
GainLossOnExtinguishmentOfSellerNote
2012000
CY2022 ater Gain Loss On Initial Issuance Of Equity
GainLossOnInitialIssuanceOfEquity
-18669000
CY2022 ater Exercise Of Prefunded Warrants Value
ExerciseOfPrefundedWarrantsValue
15039000
CY2022 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
767000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
46834000
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
18982000
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-3254000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-138859000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
26455000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-470000
CY2021 ater Loss On Initial Issuance Of Warrant
LossOnInitialIssuanceOfWarrant
20147000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-45000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
281000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-235492000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-196668000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
532000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-376000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-236024000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-196292000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.67
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.67
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.95
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.95
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35379005
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35379005
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66529565
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66529565
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-236024000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-196292000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-477000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-676000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-477000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-676000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-236501000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-196968000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
23382000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-236024000
CY2021 ater Stock Issued During Period Value Common Stock Upon Exercise Of Stock Option Grants
StockIssuedDuringPeriodValueCommonStockUponExerciseOfStockOptionGrants
9033000
CY2021 ater Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
40318000
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
47369000
CY2021 ater Issuance Of Restricted Stock Awards
IssuanceOfRestrictedStockAwards
7669000
CY2021 ater Issuance Of Warrants To High Trail Value
IssuanceOfWarrantsToHighTrailValue
39016000
CY2021 ater Issuance Of Warrants To Midcap
IssuanceOfWarrantsToMidcap
589000
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
97088000
CY2021 ater Reclassification Of Warrants To Liability
ReclassificationOfWarrantsToLiability
-21260000
CY2021 ater Fair Value Of Warrant Modification On Extinguishment
FairValueOfWarrantModificationOnExtinguishment
17399000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
36735000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22696000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-477000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
224228000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-196292000
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000
CY2022 ater Stock Issued During Period Value Common Stock
StockIssuedDuringPeriodValueCommonStock
43000
CY2022 ater Adjustments To Additional Paid In Capital Gain Loss On Initial Issuance Of Equity
AdjustmentsToAdditionalPaidInCapitalGainLossOnInitialIssuanceOfEquity
18669000
CY2022 ater Issuance Of Warrants To Contractors
IssuanceOfWarrantsToContractors
1137000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11184000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-676000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
101952000
CY2021 us-gaap Profit Loss
ProfitLoss
-236024000
CY2022 us-gaap Profit Loss
ProfitLoss
-196292000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7326000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7521000
CY2021 ater Provision For Sales Returns
ProvisionForSalesReturns
43000
CY2022 ater Provision For Sales Returns
ProvisionForSalesReturns
56000
CY2021 ater Amortization Of Deferred Financing Costs And Debt Discounts
AmortizationOfDeferredFinancingCostsAndDebtDiscounts
7742000
CY2022 ater Amortization Of Deferred Financing Costs And Debt Discounts
AmortizationOfDeferredFinancingCostsAndDebtDiscounts
429000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
28987000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
14594000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-30529000
CY2022 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-5240000
CY2021 ater Gain Loss In Connection With Settlement Of Earnout
GainLossInConnectionWithSettlementOfEarnout
-4164000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
26455000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-470000
CY2022 ater Gain In Connection With Settlement Of Note Payable
GainInConnectionWithSettlementOfNotePayable
2012000
CY2021 ater Loss On Initial Issuance Of Warrant
LossOnInitialIssuanceOfWarrant
20147000
CY2022 ater Issuance Of Common Stock
IssuanceOfCommonStock
43000
CY2022 ater Gain Loss On Initial Issuance Of Equity
GainLossOnInitialIssuanceOfEquity
-18669000
CY2021 ater Provision For Barter Credits
ProvisionForBarterCredits
1000000
CY2022 ater Provision For Barter Credits
ProvisionForBarterCredits
1643000
CY2021 ater Loss From Derivative Liability Discount Related To Term Loan
LossFromDerivativeLiabilityDiscountRelatedToTermLoan
3254000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
120409000
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3118000
CY2021 ater Allowance For Doubtful Accounts And Other
AllowanceForDoubtfulAccountsAndOther
4200000
CY2022 ater Allowance For Doubtful Accounts And Other
AllowanceForDoubtfulAccountsAndOther
367000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4554000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5596000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
19303000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-19438000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7856000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5564000
CY2021 ater Increase Decrease In Accounts Payable Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedAndOtherLiabilities
14120000
CY2022 ater Increase Decrease In Accounts Payable Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedAndOtherLiabilities
-10910000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41969000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17477000
CY2021 ater Payments For Purchase Of Fixed Assets
PaymentsForPurchaseOfFixedAssets
32000
CY2022 ater Payments For Purchase Of Fixed Assets
PaymentsForPurchaseOfFixedAssets
82000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
595000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44905000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-677000
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
9085000
CY2021 ater Proceeds From Cancellation Of Warrant
ProceedsFromCancellationOfWarrant
16957000
CY2021 ater Proceeds From Issuance Of Common Stock Follow On Public Offering Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockFollowOnPublicOfferingNetOfIssuanceCosts
36735000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
46834000
CY2021 ater Proceeds From Payments For Stock Options Exercised
ProceedsFromPaymentsForStockOptionsExercised
9033000
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
10495000
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3423000
CY2021 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7971000
CY2022 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
3983000
CY2021 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
48750000
CY2022 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
136687000
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
28274000
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
148907000
CY2021 ater Proceeds From Insurance Financing Activities
ProceedsFromInsuranceFinancingActivities
2424000
CY2022 ater Proceeds From Insurance Financing Activities
ProceedsFromInsuranceFinancingActivities
2099000
CY2021 ater Payments Of Insurance Obligation Financing Activities
PaymentsOfInsuranceObligationFinancingActivities
3048000
CY2022 ater Payments Of Insurance Obligation Financing Activities
PaymentsOfInsuranceObligationFinancingActivities
2311000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
95569000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26996000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-477000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-528000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8218000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8314000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30097000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
38315000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
38315000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
46629000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30317000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43574000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7849000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2926000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
149000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
129000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
38315000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
46629000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
5611000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
1875000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
41000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
100000
CY2022 ater Non Cash Consideration Paid To Contractors
NonCashConsiderationPaidToContractors
1137000
CY2021 ater Modification Of Warrants Between Equity And Liability
ModificationOfWarrantsBetweenEquityAndLiability
75828000
CY2021 ater Non Cash Consideration Paid To Contractors
NonCashConsiderationPaidToContractors
7289000
CY2021 ater Debt Original Issue Discount
DebtOriginalIssueDiscount
2475000
CY2021 ater Non Cash Fair Value Of Contingent Considerations
NonCashFairValueOfContingentConsiderations
20971000
CY2021 ater Discount Of Debt Relating To Warrants Issuance
DiscountOfDebtRelatingToWarrantsIssuance
51284000
CY2021 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
16550000
CY2021 us-gaap Stock Issued1
StockIssued1
125562000
CY2021 ater Issuance Of Common Stock Healing Solutions Earnout Settlement
IssuanceOfCommonStockHealingSolutionsEarnoutSettlement
7914000
CY2022 ater Issuance Of Common Stock Related To Exercise Of Warrants
IssuanceOfCommonStockRelatedToExerciseOfWarrants
767000
CY2022 ater Non Cash Initial Issuance Of Equity
NonCashInitialIssuanceOfEquity
18669000
CY2022 ater Issuance Of Warrants In Connection With Offering
IssuanceOfWarrantsInConnectionWithOffering
18982000
CY2022 ater Non Cash Issuance Of Common Stock
NonCashIssuanceOfCommonStock
43000
CY2022 ater Exercise Of Pre Funded Warrants
ExerciseOfPreFundedWarrants
15039000
CY2022 ater Substantial Doubt About Going Concern Net Loss
SubstantialDoubtAboutGoingConcernNetLoss
196300000
CY2022 ater Substantial Doubt About Going Concern Net Cash Used In Operating Activities
SubstantialDoubtAboutGoingConcernNetCashUsedInOperatingActivities
17500000
CY2022Q4 ater Substantial Doubt About Going Concern Unrestricted Cash And Cash Equivalents
SubstantialDoubtAboutGoingConcernUnrestrictedCashAndCashEquivalents
43600000
CY2022Q4 ater Substantial Doubt About Going Concern Accumulated Deficit
SubstantialDoubtAboutGoingConcernAccumulatedDeficit
625300000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">—Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period covered by the financial statements and accompanying notes. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from those estimates.</span></p>
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0.0
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
400000
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Concentration of Credit Risk</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">—Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and accounts receivable. The Company maintains cash and restricted cash with various domestic and foreign financial institutions of high credit quality. The Company performs periodic evaluations of the relative credit standing of all of the aforementioned institutions. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company does have cash deposits at financial institutions in excess of the insured amount of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million by the Federal Deposit Insurance Corporation.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company’s accounts receivables are derived from sales contracts with a large number of customers. The Company maintains reserves for potential credit losses on customer accounts when deemed necessary. Significant customers are those which represent more than 10% of the Company’s total net revenue or gross accounts receivable balance at the balance sheet date. During the years-ended December 31, 2021 and 2022, the Company had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> one customer that accounted for 10% or more of total net revenue. In addition, as of December 31, 2021 and 2022, the Company had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> customers that accounted for 10% or more of gross accounts receivable. As of December 31, 2021 and 2022, approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%, respectively, of its accounts receivable is held by the Company’s sales platform vendor, Amazon, which collects money on the Company’s behalf from its customers.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company’s business is reliant on one key vendor which currently provides the Company with its sales platform, logistics and fulfillment operations, including certain warehousing for the Company’s net goods, and invoicing and collection of its revenue from the Company’s end customers. In 2021, approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Company’s revenue was through or with the Amazon sales platform and in 2022, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of its net revenue was through or with the Amazon sales platform.</span></p>
CY2022Q4 ater Cash Deposits At Financial Institutions In Excess Of Insured Amount
CashDepositsAtFinancialInstitutionsInExcessOfInsuredAmount
300000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
2926000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2440000
CY2022 ater Income Tax Benefit Recognition Criteria Percentage Threshold
IncomeTaxBenefitRecognitionCriteriaPercentageThreshold
0.50
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
247767000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
221170000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
247767000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
221170000
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
29000000.0
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
90900000
CY2022Q3 us-gaap Goodwill
Goodwill
0
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
700000
CY2022Q4 us-gaap Goodwill
Goodwill
500000
CY2022Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
500000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
120400000
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3100000
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3100000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1991000
CY2021Q4 ater Consulting Fees
ConsultingFees
2263000
CY2021Q4 ater Amazon Global Logistics
AmazonGlobalLogistics
2865000
CY2022Q4 ater Amazon Global Logistics
AmazonGlobalLogistics
576000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1331000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1426000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21034000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8261000
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
700000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
700000
CY2022Q1 ater Operating Lease Right Of Use Asset Current
OperatingLeaseRightOfUseAssetCurrent
200000
CY2022Q1 ater Operating Lease Right Of Use Asset Non Current
OperatingLeaseRightOfUseAssetNonCurrent
100000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
162000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
48079000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
34374000
CY2021Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
14966000
CY2022Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
9292000
CY2021Q4 us-gaap Inventory Net
InventoryNet
63045000
CY2022Q4 us-gaap Inventory Net
InventoryNet
43666000
CY2021Q4 us-gaap Other Inventory Warehouse
OtherInventoryWarehouse
8400000
CY2022Q4 us-gaap Other Inventory Warehouse
OtherInventoryWarehouse
8600000
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
10478000
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4882000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
367000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10478000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4515000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
53000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
331000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
461000
CY2021Q4 ater Accrued Logistics Costs Current
AccruedLogisticsCostsCurrent
578000
CY2022Q4 ater Accrued Logistics Costs Current
AccruedLogisticsCostsCurrent
609000
CY2021Q4 ater Product Related Accruals
ProductRelatedAccruals
2984000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1813000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1894000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
559000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1041000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1254000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
853000
CY2021 us-gaap Depreciation
Depreciation
200000
CY2022 us-gaap Depreciation
Depreciation
400000
CY2022 ater Change In Fair Value Of Warrant Liability
ChangeInFairValueOfWarrantLiability
3473000
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
3473000
CY2021Q4 ater Prepaid Inventory
PrepaidInventory
4137000
CY2022Q4 ater Prepaid Inventory
PrepaidInventory
1342000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
7998000
CY2022Q4 ater Product Related Accruals
ProductRelatedAccruals
1248000
CY2021Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
678000
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
711000
CY2021Q4 ater Sales Return Reserve
SalesReturnReserve
590000
CY2022Q4 ater Sales Return Reserve
SalesReturnReserve
646000
CY2021Q4 ater Accrued Fulfillment Expense
AccruedFulfillmentExpense
744000
CY2022Q4 ater Accrued Fulfillment Expense
AccruedFulfillmentExpense
755000
CY2021Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
967000
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
356000
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
4449000
CY2022Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1467000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
338000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
190000
CY2022Q4 ater Warrant Liability Current
WarrantLiabilityCurrent
3473000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5800000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4285000
CY2021Q4 ater Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
17621000
CY2022Q4 ater Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
14254000
CY2021 ater Line Of Credit Facility And Term Loan Interest Expense
LineOfCreditFacilityAndTermLoanInterestExpense
400000
CY2021 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
100000
CY2021Q3 us-gaap Accounts Receivable Sale
AccountsReceivableSale
65000000.0
CY2021Q2 ater Warrants Prior To Day
WarrantsPriorToDay
60 days
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2666667
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-138900000
CY2021 us-gaap Interest Expense
InterestExpense
13250000
CY2022 us-gaap Interest Expense
InterestExpense
2696000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
595000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
93000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-12655000
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2603000
CY2022 us-gaap Common Stock Voting Rights
CommonStockVotingRights
The Company has one class of common shares issued and available. Each share of common stock has the right to one vote per share
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
522905
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.25
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M7D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
25971000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
154309
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.24
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
368596
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.26
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M20D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
368596
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.26
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M20D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
368596
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
9.26
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y10M20D
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28987000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14594000
CY2021Q4 us-gaap Purchase Obligation
PurchaseObligation
32300000
CY2022Q4 us-gaap Purchase Obligation
PurchaseObligation
13500000
CY2021Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
700000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-233846000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-196166000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1646000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-502000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-235492000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-196668000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
72000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
101000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
265000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
69000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
337000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
170000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
253000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-270000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
32000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-35000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-90000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-241000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
195000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-546000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
532000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-376000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-49454000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-41300000
CY2021 ater Income Tax Rate Reconciliation Permanent Differences
IncomeTaxRateReconciliationPermanentDifferences
3000
CY2021 ater Income Tax Rate Reconciliation Debt Extinguishment
IncomeTaxRateReconciliationDebtExtinguishment
33746000
CY2022 ater Income Tax Rate Reconciliation Debt Extinguishment
IncomeTaxRateReconciliationDebtExtinguishment
-481000
CY2021 ater Income Tax Rate Reconciliation Warrant Liabilities
IncomeTaxRateReconciliationWarrantLiabilities
11066000
CY2022 ater Income Tax Rate Reconciliation Warrant Liabilities
IncomeTaxRateReconciliationWarrantLiabilities
4455000
CY2021 ater Income Tax Rate Reconciliation Stock Compensation
IncomeTaxRateReconciliationStockCompensation
10602000
CY2022 ater Income Tax Rate Reconciliation Stock Compensation
IncomeTaxRateReconciliationStockCompensation
4410000
CY2021 ater Income Tax Rate Reconciliation Change In Fair Value Contingent Consideration
IncomeTaxRateReconciliationChangeInFairValueContingentConsideration
-3143000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
3000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-44000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
14000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-6424000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-5644000
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
264000
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-389000
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-5577000
CY2022 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-352000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
9493000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
38908000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
532000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-376000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0008
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0019
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
130000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
36250000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
51889000
CY2021Q4 ater Deferred Tax Assets Stock Options
DeferredTaxAssetsStockOptions
3592000
CY2022Q4 ater Deferred Tax Assets Stock Options
DeferredTaxAssetsStockOptions
1712000
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
15000
CY2021Q4 ater Deferred Tax Assets Tax Deferred Expense Interest Expense Limitation
DeferredTaxAssetsTaxDeferredExpenseInterestExpenseLimitation
10151000
CY2022Q4 ater Deferred Tax Assets Tax Deferred Expense Interest Expense Limitation
DeferredTaxAssetsTaxDeferredExpenseInterestExpenseLimitation
10959000
CY2022Q4 ater Deferred Tax Assets Intangibles
DeferredTaxAssetsIntangibles
181000
CY2022Q4 ater Intangibles Indefinite Life
IntangiblesIndefiniteLife
21386000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2364000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1972000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
52502000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
88099000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
47316000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
86224000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5186000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1875000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
18000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
1528000
CY2021Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
3562000
CY2022Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
1808000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
560000
CY2021Q4 ater Deferred Tax Liabilities Contingent Consideration
DeferredTaxLiabilitiesContingentConsideration
1084000
CY2022Q4 ater Deferred Tax Liabilities Contingent Consideration
DeferredTaxLiabilitiesContingentConsideration
1092000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
130000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
130000
CY2021Q4 ater Deferred Tax Liabilities Net Of Valuation Allowance
DeferredTaxLiabilitiesNetOfValuationAllowance
6882000
CY2022Q4 ater Deferred Tax Liabilities Net Of Valuation Allowance
DeferredTaxLiabilitiesNetOfValuationAllowance
3033000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1696000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1158000
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
152000000.0
CY2021 ater Operating Loss Carry Forward Expiration Year
OperatingLossCarryForwardExpirationYear
2034
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
216400000
CY2022 ater Operating Loss Carry Forward Expiration Year
OperatingLossCarryForwardExpirationYear
2034
CY2022 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
The Company’s ability to utilize its NOL carryforwards may be limited pursuant to Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), if the Company has had a change in ownership of more than 50% of its capital stock over a three-year period pursuant to Section 382 of the Code. These complex changes of ownership rules generally focus on ownership changes involving stockholders owning directly or indirectly 5% or more of a company’s stock, including certain public “groups” of stockholders as set forth by Section 382 of the Code, including those arising from new stock issuances and other equity transactions.
CY2022Q3 ater Corporate Alternative Minimum Tax
CorporateAlternativeMinimumTax
0.15
CY2022Q3 ater Excise Tax
ExciseTax
0.01
CY2022Q2 ater Percentage Of Investment Tax Credit
PercentageOfInvestmentTaxCredit
0.25
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-236024000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-196292000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35379005
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35379005
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66529565
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66529565
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.67
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.67
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.95
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.95
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3027361
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13409769
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
247767000
CY2021 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
264725000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-34077000
CY2021 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
-30771000
CY2021 ater Acquisition Date Fair Value Of Contingent Earn Out Liabilities
AcquisitionDateFairValueOfContingentEarnOutLiabilities
5200000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
0
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
22531000
CY2021 ater Acquisition Date Fair Value Of Contingent Earn Out Liabilities And Inventory To Be Settled In Shares
AcquisitionDateFairValueOfContingentEarnOutLiabilitiesAndInventoryToBeSettledInShares
20971000
CY2021 ater Business Combination Contingent Consideration Change In Fair Value Of Contingent Earn Out Liabilities
BusinessCombinationContingentConsiderationChangeInFairValueOfContingentEarnOutLiabilities
-30529000
CY2021 ater Contingent Consideration Earn Out Payments
ContingentConsiderationEarnOutPayments
3750000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
9223000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
9223000
CY2022 ater Business Combination Contingent Consideration Change In Fair Value Of Contingent Earn Out Liabilities
BusinessCombinationContingentConsiderationChangeInFairValueOfContingentEarnOutLiabilities
-5240000
CY2022 ater Contingent Consideration Earn Out Payments
ContingentConsiderationEarnOutPayments
3983000
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
29000000.0
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
90900000
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
700000
CY2022Q4 us-gaap Goodwill
Goodwill
500000
CY2022Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
500000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
120400000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
31944000
CY2021 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
40500000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-7489000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
64955000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
72444000
CY2022 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
192000
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3118000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14761000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
54757000
CY2022Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3100000
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3100000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
6821000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
6801000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
6759000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
6759000
CY2022Q4 ater Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
27617000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
54757000
CY2022 dei Auditor Name
AuditorName
Deloitte & Touche LLP

Files In Submission

Name View Source Status
ater-20221231_cal.xml Edgar Link unprocessable
ater-20221231_def.xml Edgar Link unprocessable
0000950170-23-008509-index-headers.html Edgar Link pending
0000950170-23-008509-index.html Edgar Link pending
0000950170-23-008509.txt Edgar Link pending
0000950170-23-008509-xbrl.zip Edgar Link pending
ater-20221231.htm Edgar Link pending
ater-20221231.xsd Edgar Link pending
ater-ex10_33.htm Edgar Link pending
ater-ex21_1.htm Edgar Link pending
ater-ex23_1.htm Edgar Link pending
ater-ex31_1.htm Edgar Link pending
ater-ex31_2.htm Edgar Link pending
ater-ex32_1.htm Edgar Link pending
ater-ex4_9.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img68829427_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
ater-20221231_lab.xml Edgar Link unprocessable
ater-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ater-20221231_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending